Chemical activators of transmembrane protein 231 can initiate a cascade of intracellular biochemical events leading to its activation. Calcium chloride, through its role in elevating intracellular calcium levels, acts as a direct activator of signaling pathways that involve transmembrane protein 231. This rise in calcium can engage various kinases that phosphorylate and activate this protein. Similarly, ionomycin, by acting as a calcium ionophore, increases calcium concentration within the cell, triggering calmodulin-dependent kinases that may target transmembrane protein 231. A23187, another calcium ionophore, also raises intracellular calcium, setting off a sequence of phosphorylation events affecting the protein. Thapsigargin contributes to the activation of transmembrane protein 231 by hindering the sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase, causing an upsurge in cytosolic calcium levels and, consequently, the activation of the protein. Bay K8644, an L-type calcium channel agonist, similarly prompts an increase in intracellular calcium, which can directly impact the activation state of transmembrane protein 231.
Further, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), a kinase that phosphorylates and thereby activates transmembrane protein 231. Forskolin, by stimulating adenylate cyclase, leads to an increase in cAMP levels within the cell, which activates protein kinase A (PKA). PKA can then phosphorylate transmembrane protein 231, influencing its activation status. 8-Bromo-cAMP, a stable cAMP analog, also engages PKA and similarly leads to the phosphorylation and subsequent activation of transmembrane protein 231. BAPTA-AM, a cell-permeable calcium chelator, upon hydrolysis, increases the free calcium concentration inside the cell, which can activate transmembrane protein 231. Spermine NONOate releases nitric oxide that modulates signaling pathways and can influence the activation of the protein. Lastly, okadaic acid, by inhibiting protein phosphatases, prevents dephosphorylation, which can result in the sustained activation of transmembrane protein 231. Each of these chemicals, through their unique mechanisms, contributes to the regulation of intracellular signaling pathways that converge on transmembrane protein 231, influencing its activation state.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $65.00 $262.00 | 1 | |
Calcium chloride can activate transmembrane protein 231 by increasing intracellular calcium levels, which is a second messenger in various signaling pathways. This influx can trigger downstream signaling events leading to the activation of the protein. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in a multitude of signaling pathways. PKC can phosphorylate transmembrane protein 231, leading to its functional activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin stimulates adenylate cyclase increasing cAMP levels, which can activate PKA. PKA phosphorylation can lead to the activation of transmembrane protein 231 through downstream effects on signaling pathways the protein is involved in. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin, a calcium ionophore, increases intracellular Ca²⁺ concentrations, activating calmodulin-dependent kinases, which may phosphorylate and activate transmembrane protein 231. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Bromo-cAMP, a cAMP analog, activates PKA. Activated PKA can phosphorylate various proteins including transmembrane protein 231, leading to its activation within its signaling cascade. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels. Elevated calcium can activate signaling pathways that include activation of transmembrane protein 231 through phosphorylation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase (SERCA), leading to increased cytosolic calcium concentrations. This can activate transmembrane protein 231 as part of the calcium signaling pathway. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
BAPTA-AM is a cell-permeant calcium chelator that, upon intracellular hydrolysis, increases free calcium levels. This calcium can activate signaling pathways involving transmembrane protein 231. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
Bay K8644 acts as an L-type calcium channel agonist, increasing calcium influx. The increase in intracellular calcium can activate signaling mechanisms that lead to the activation of transmembrane protein 231. | ||||||
Spermine NONOate | 136587-13-8 | sc-202816 sc-202816A | 5 mg 25 mg | $52.00 $192.00 | 5 | |
Spermine NONOate releases nitric oxide which can influence signaling pathways involving cyclic GMP, potentially leading to the activation of transmembrane protein 231. | ||||||